Publications by authors named "Arne Pigorsch"

Inhibition of cyclooxygenase-2 (COX-2) is a promising anti-inflammatory therapeutic strategy, but long-term medication with COX-2-inhibitors (coxibs) may be associated with adverse cardiovascular effects. Functionalization of existing lead structures with nitric oxide (NO)-releasing moieties is an auspicious approach to minimize these effects. In this regard, an organic nitrate (-O-NO2) substituent was introduced at a (pyrazolyl)benzenesulfonamide lead structure.

View Article and Find Full Text PDF

A new compound class of diaryl-substituted heterocycles with tricyclic dihydropyrrolo[3,2,1-hi]indole and pyrrolo[3,2,1-hi]indole core structures has been designed and was synthesized by a modular sequence of Friedel-Crafts acylation, amide formation, and McMurry cyclization. This synthesis route represents a novel and versatile access toward dihydropyrrolo[3,2,1-hi]indoles and is characterized by good chemical yields and high modularity. From a set of 19 derivatives, 11 candidates were selected for determination of their COX inhibition potency and were found to be selective inhibitors with high affinity to COX-2 (IC50 ranging from 20-2500 nM and negligible inhibition of COX-1).

View Article and Find Full Text PDF

A series of high-temperature solid state chemical reactions was carried out in the quasi-quarternary mixed-halide Cs-Zr-B-(Cl,I) system with stoichiometries aiming for zirconium cluster phases of the Cs(2)[(Zr(6)B)X(15)] type (X = mixture of Cl + I). In the phase range from ~ Cs(2)[(Zr(6)B)Cl(13)I(2)] to Cs(2)[(Zr(6)B)Cl(3)I(12)] the structures of the obtained cluster phases are derived from the orthorhombic CsK[(Zr(6)B)Cl(15)]. At a composition of Cs(2)[(Zr(6)B)Cl(~10) I(~4)] a lower symmetry, monoclinic derivative has been found.

View Article and Find Full Text PDF